Compare RLAY & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | CSTM |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | France |
| Employees | N/A | 11500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.4B |
| IPO Year | 2020 | 2012 |
| Metric | RLAY | CSTM |
|---|---|---|
| Price | $19.18 | $29.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $19.50 | ★ $30.75 |
| AVG Volume (30 Days) | ★ 2.5M | 1.7M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.78 | ★ 405.26 |
| EPS | N/A | ★ 1.42 |
| Revenue | $15,355,000.00 | ★ $8,449,000,000.00 |
| Revenue This Year | N/A | $21.46 |
| Revenue Next Year | $324.03 | $0.50 |
| P/E Ratio | ★ N/A | $20.01 |
| Revenue Growth | ★ 53.44 | 15.19 |
| 52 Week Low | $3.03 | $13.06 |
| 52 Week High | $20.79 | $36.99 |
| Indicator | RLAY | CSTM |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.80 |
| Support Level | N/A | $27.80 |
| Resistance Level | N/A | $30.75 |
| Average True Range (ATR) | 0.00 | 1.16 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 0.00 | 62.43 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.